News for Agent

Daily business news: funding, M&A, launches

Legal & Disputes

SueWallSt Opens Humana Investigation Over Medicare Advantage Audit Disclosures

By ·

Key takeaways

  • SueWallSt notified investors of a pending investigation into whether Humana adequately disclosed its Medicare Advantage audit and repayment exposure.
  • Humana shares fell more than 12.9% on November 18, 2026, after reports of a proposed federal CRUSH rule on Medicare Advantage fraud, waste and improper payments.
  • Investors who bought Humana stock and suffered losses may seek recovery regardless of whether they still hold the shares, according to SueWallSt.

SueWallSt notified Humana investors on November 19, 2026 of a pending investigation into whether the health insurer adequately disclosed its exposure to Medicare Advantage audit and repayment risk. The PR Newswire announcement followed a November 18, 2026 decline of more than 12.9% in Humana shares after reports of a proposed federal rule.

What The Humana Investigation Covers

The investigation concerns potential securities law violations, including whether Humana's public disclosures adequately addressed its Medicare Advantage audit and repayment exposure. SueWallSt said the proposal reportedly calls for stronger Medicare Advantage audits and expanded recovery of unsupported risk-adjustment payments. Early reports on November 18 showed Humana down 3.95% at $443.12, and later reports put the decline at more than 12.9%.

SueWallSt said eligibility depends on when investors bought Humana stock, not on whether they still own the shares. Joseph E. Levi, Esq. is the contact for investors seeking a review of their losses. "Whether you still hold HUM or already sold at a loss, you may have the right to seek recovery," the notice states. SueWallSt is powered by Levi & Korsinsky LLP.

Humana's Medicare Advantage Business At A Glance

Humana is a Louisville-based health insurer and integrated care delivery company founded in 1964, providing Medicare Advantage, Medicare Supplement, Part D and Medicaid managed care plans through its CenterWell subsidiary, according to akta.pro company records. The same records show Humana generated $137.2 billion in revenue over the trailing twelve months as of mid-2026, after $129.6 billion in total sales for FY2025. Humana ended Q1 2026 with 7.1 million individual Medicare Advantage members, 1.3 million more than at the end of 2025.

How Humana's Audit Risk Built Up

On November 17, 2026, Humana shares fell 4.24% to $441.71 after HHS unveiled a proposed rule expanding Medicare Advantage overpayment recovery, Yahoo reported. CMS expects the audit changes to recover about $9 billion per payment year, with retroactive audits reaching back to 2018. On November 18, 2026, Humana completed a multi-series bond buyback of up to $1.5 billion in senior notes, Yahoo reported.

What Comes Next For Humana Investors

SueWallSt said no immediate action is required to remain eligible to participate in the investigation, and that investors may gather brokerage records showing purchase dates, share quantities and prices paid.

Companies in this story

Sources

Machine-readable: Markdown · JSON